Randal J Thomas1, Hsu-Hang Huang2. 1. Mayo Clinic Cardiac Rehabilitation Program, Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA. thomas.randal@mayo.edu. 2. Mayo Clinic Cardiac Rehabilitation Program, Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA.
Abstract
PURPOSE OF REVIEW: To provide updated information on the science and practice of cardiac rehabilitation (CR). RECENT FINDINGS: Evidence continues to mount that supports the many benefits of CR as well as the important gap in delivering CR to all eligible patients. Recent studies have identified center-based and home-based strategies to improve the reach and impact of CR. Cardiac rehabilitation is a systematic, evidence-based approach to deliver effective secondary CVD preventive therapies to individuals with cardiovascular conditions. Because of a number of benefits that have been associated with CR, clinical practice guidelines strongly endorse CR services for eligible patients. Research supports CR as a high value service, with evidence of favorable clinical outcomes and costs. Unfortunately, a significant gap exists in CR participation due to a number of patient-, provider-, and system-level barriers. Solutions to most of these barriers have been identified and involve systematic approaches to CR delivery. The future is bright for CR as new strategies, new policies, and new methods of delivery continue to develop to help provide CR services to all eligible patients.
PURPOSE OF REVIEW: To provide updated information on the science and practice of cardiac rehabilitation (CR). RECENT FINDINGS: Evidence continues to mount that supports the many benefits of CR as well as the important gap in delivering CR to all eligible patients. Recent studies have identified center-based and home-based strategies to improve the reach and impact of CR. Cardiac rehabilitation is a systematic, evidence-based approach to deliver effective secondary CVD preventive therapies to individuals with cardiovascular conditions. Because of a number of benefits that have been associated with CR, clinical practice guidelines strongly endorse CR services for eligible patients. Research supports CR as a high value service, with evidence of favorable clinical outcomes and costs. Unfortunately, a significant gap exists in CR participation due to a number of patient-, provider-, and system-level barriers. Solutions to most of these barriers have been identified and involve systematic approaches to CR delivery. The future is bright for CR as new strategies, new policies, and new methods of delivery continue to develop to help provide CR services to all eligible patients.
Authors: L David Hillis; Peter K Smith; Jeffrey L Anderson; John A Bittl; Charles R Bridges; John G Byrne; Joaquin E Cigarroa; Verdi J Disesa; Loren F Hiratzka; Adolph M Hutter; Michael E Jessen; Ellen C Keeley; Stephen J Lahey; Richard A Lange; Martin J London; Michael J Mack; Manesh R Patel; John D Puskas; Joseph F Sabik; Ola Selnes; David M Shahian; Jeffrey C Trost; Michael D Winniford Journal: Circulation Date: 2011-11-07 Impact factor: 29.690
Authors: Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman Journal: Circulation Date: 2014-09-23 Impact factor: 29.690
Authors: Quinn R Pack; Lezlie L Johnson; Laurie M Barr; Stephanie R Daniels; Anne D Wolter; Ray W Squires; Carmen M Perez-Terzic; Randal J Thomas Journal: J Cardiopulm Rehabil Prev Date: 2013 May-Jun Impact factor: 2.081
Authors: Shannon M Dunlay; Brandi J Witt; Thomas G Allison; Sharonne N Hayes; Susan A Weston; Ellen Koepsell; Véronique L Roger Journal: Am Heart J Date: 2009-09-29 Impact factor: 4.749
Authors: Jose A Suaya; William B Stason; Philip A Ades; Sharon-Lise T Normand; Donald S Shepard Journal: J Am Coll Cardiol Date: 2009-06-30 Impact factor: 24.094
Authors: James A Blumenthal; Andrew Sherwood; Michael A Babyak; Lana L Watkins; Patrick J Smith; Benson M Hoffman; C Virginia F O'Hayer; Stephanie Mabe; Julie Johnson; P Murali Doraiswamy; Wei Jiang; Douglas D Schocken; Alan L Hinderliter Journal: J Am Coll Cardiol Date: 2012-08-01 Impact factor: 24.094
Authors: Randal J Thomas; Alexis L Beatty; Theresa M Beckie; LaPrincess C Brewer; Todd M Brown; Daniel E Forman; Barry A Franklin; Steven J Keteyian; Dalane W Kitzman; Judith G Regensteiner; Bonnie K Sanderson; Mary A Whooley Journal: Circulation Date: 2019-05-13 Impact factor: 39.918
Authors: Elena Salmoirago-Blotcher; Peter M Wayne; Shira Dunsiger; Julie Krol; Christopher Breault; Beth C Bock; Wen-Chih Wu; Gloria Y Yeh Journal: J Am Heart Assoc Date: 2017-10-11 Impact factor: 5.501